Your browser doesn't support javascript.
loading
The metabolic fate of fenclozic acid in chimeric mice with a humanized liver.
Ekdahl, Anja; Weidolf, Lars; Baginski, Matthew; Morikawa, Yoshio; Thompson, Richard A; Wilson, Ian D.
Afiliação
  • Ekdahl A; MetaSafe AB, Forskargatan 20J, Södertälje, Sweden.
  • Weidolf L; DMPK, Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden. lars.weidolf@astrazeneca.com.
  • Baginski M; Research Planning and Business Development Department, PhoenixBio USA Corporation, 65 Broadway, Suite 605, New York, NY, 10006, USA.
  • Morikawa Y; Research Planning and Business Development Department, PhoenixBio USA Corporation, 65 Broadway, Suite 605, New York, NY, 10006, USA.
  • Thompson RA; DMPK, Respiratory, Inflammation and Autoimmunity IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Wilson ID; Department of Surgery and Cancer, Imperial College, Exhibition Rd, South Kensington, London, SW7 2AZ, UK. i.wilson@imperial.ac.uk.
Arch Toxicol ; 92(9): 2819-2828, 2018 09.
Article em En | MEDLINE | ID: mdl-30094548
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tiazóis / Fígado Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tiazóis / Fígado Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article